Overview
Lobbying Costs
150,000€
Financial year: Jan 2019 - Dec 2019
Lobbyists (Full time equivalent)
1.5 Fte (5)
Lobbyists with EP accreditation
0
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
Avicenna Alliance -
EU Transparency Register
551058626331-14 First registered on 14 Mar 2017
Goals / Remit
The ASBL aims at the improvement of public health through the promotion of in-silico medicine.
The activities that enable the achievement of the objectives of the ASBL include: the promotion of policy and legislation at National and European level; engagement with policy-makers through meetings and events; the undertaking of collaborative scientific research projects furthering and supporting the objectives of the ASBL; the promotion of in-silico medicine through social media and traditional media outlets; the development of policy and communication material.Main EU files targeted
eHealth, Clinical Trials Regulation, EMA Regulation, Data Protection Regulation, Medical Devices Regulation, mHealth, EMA Modelling and Simulation policies, Orphan medicinal products, Blood Directive, Tissues & Cells Directive, Horizon Europe, Beating cancer strategy, Digital Agenda
Address
Head Office
10 Rue Guimard
Brussels 1040
BELGIUM -
People
Total lobbyists declared
5
Employment time Lobbyists 50% 1 25% 4 Lobbyists (Full time equivalent)
1.5
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
Current Secretariat of the Avicenna Alliance is RPP Group
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
III - Non-governmental organisations
Subcategory
Non-governmental organisations, platforms and networks and similar
-
Networking
Affiliation
Member of the European Forum for Good Clinical Practice (EFGCP)
Member organisations
http://avicenna-alliance.com/membership/
-
Financial Data
Closed financial year
Jan 2019 - Dec 2019
Lobbying costs for closed financial year
150,000€
Other financial info
Avicenna was established as a legal entity (non-profit) in April 2016 under Belgian law. Prior to this time it operated as an informal platform of industries and researchers.
Accounting for the Alliance began after its' legal establishment -
EU Structures
Groups (European Commission)
eHealth Stakeholder Group#E02769 #http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=2769 #Member #C
Groups (European Parliament)
None
Communication activities
Organisation of logistics of European Parliament event on in silico medicine;
Contact with the EMA, European Commission and Parliament on the topic of in silico medicine;
All information can be found at avicenna-alliance.com or contact us directly for any detialsOther activities
None declared
Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 08 Feb 2018 Location Brussels Subject Computer modelling in healthcare Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
Other Lobbyists